The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital


11 Mar 2020

IAS statement on the “London Patient” HIV cure case

This article was published by IAS.

“It's hard to know if this is a cure, only time will tell, but this is looking very promising,” said Sharon Lewin, IAS Governing Council member and Director of the Peter Doherty Institute for Infection and Immunity at the University of Melbourne in Australia. Lewin is also Co-Chair with Mark Dybul of the IAS initiative Towards an HIV Cure.

“No-one other than Timothy Brown, the Berlin Patient, has remained aviremic off ART for 30 months. The Mississippi baby rebounded at 27 months off ART. These cases are so rare that I think we should be excited - but it will still be essential to keep monitoring the patient's progress too.

Read the full article here.